Skip to main content
Toggle navigation
Login
Search
Home
iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet
Alessia Floerchinger, MSc
PhD Student
German Cancer Research Center (DKFZ) Heidelberg, Germany
N/A
Poster(s):
1057 - Combining CD19 CAR T cells with T cell-engaging bispecific antibody treatment enhances efficacy in murine models of CLL and ex vivo patient cultures
.jpg "Alessia Floerchinger, MSc photo")
